| |
| |
|
| Insider
Information: |
Maffuid Paul W |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
116,373 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,651,732 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,373 |
|
|
| Total
Value |
$1,651,732 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arena Pharmaceuticals Inc |
ARNA |
VP, Pharmaceutical Dev... |
2004-06-30 |
16,496 |
2003-06-30 |
0 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
|
2018-04-02 |
99,877 |
2014-12-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MBVX |
Mabvax Therapeutics Holdi... |
EXEC. VP, R AND D |
• – – |
2018-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,735) |
99,877 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXEC. VP, R AND D |
• – – |
2018-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,015 |
101,612 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2018-01-16 |
4 |
S |
$0.92 |
$35,010 |
D/D |
(38,054) |
283,703 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2018-01-12 |
4 |
S |
$0.96 |
$9,799 |
D/D |
(10,207) |
321,757 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2018-01-11 |
4 |
S |
$0.98 |
$34,463 |
D/D |
(35,166) |
331,964 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2018-01-10 |
4 |
S |
$0.96 |
$58,059 |
D/D |
(60,478) |
367,130 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2018-01-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
406,382 |
427,608 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-05-19 |
4 |
B |
$0.00 |
$5,000 |
D/D |
6,085 |
27,311 |
2.74 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-12 |
4 |
S |
$2.00 |
$2,738 |
D/D |
(1,369) |
21,226 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-11 |
4 |
S |
$2.00 |
$400 |
D/D |
(200) |
22,595 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-10 |
4 |
S |
$2.00 |
$800 |
D/D |
(400) |
22,795 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-07 |
4 |
S |
$2.01 |
$902 |
D/D |
(450) |
23,195 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-06 |
4 |
S |
$2.15 |
$1,862 |
D/D |
(867) |
23,645 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-05 |
4 |
S |
$2.15 |
$3,872 |
D/D |
(1,800) |
24,512 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-04 |
4 |
S |
$2.25 |
$2,250 |
D/D |
(1,000) |
26,312 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,045 |
27,312 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
2,079 |
12,267 |
0.01 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,944) |
75,390 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
111,334 |
116,334 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
Vice President |
• – – |
2014-12-16 |
5 |
B |
$2.85 |
$14,250 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
VP, Pharmaceutical Development |
• – – |
2004-06-30 |
4 |
A |
$4.64 |
$501 |
D/D |
108 |
16,496 |
|
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
VP, Pharmaceutical Development |
• – – |
2004-03-31 |
4 |
A |
$5.10 |
$989 |
D/D |
194 |
16,388 |
|
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
VP, Pharmaceutical Development |
• – – |
2003-12-31 |
4 |
A |
$5.10 |
$449 |
D/D |
88 |
16,194 |
|
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
VP, Pharmaceutical Development |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$826 |
D/D |
162 |
16,106 |
|
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$903 |
D/D |
177 |
15,944 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
